Palo Alto, CA2 Active Studies

Xeroderma Pigmentosum Clinical Trials in Palo Alto, CA

Find 2 actively recruiting xeroderma pigmentosum clinical trials in Palo Alto, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
90
Enrolling

Recruiting Xeroderma Pigmentosum Studies in Palo Alto

About Xeroderma Pigmentosum Clinical Trials in Palo Alto

Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.

There are currently 2 xeroderma pigmentosum clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 90 participants. Research is being sponsored by Stanford University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Xeroderma Pigmentosum Clinical Trials in Palo Alto — FAQ

Are there xeroderma pigmentosum clinical trials in Palo Alto?

Yes, there are 2 xeroderma pigmentosum clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What xeroderma pigmentosum treatments are being tested?

The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.

Data updated July 19, 2026 from ClinicalTrials.gov